AIM
LLY icon

Acropolis Investment Management’s Eli Lilly LLY Stock Holding History

Acropolis Investment Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.42M Buy
2,014
+61
+3% +$62.3K 0.1% 74
2026
Q1 		$1.8M Sell
1,953
-97
-5% -$98.3K 0.08% 82
2025
Q4 		$2.2M Buy
2,050
+210
+11% +$201K 0.1% 71
2025
Q3 		$1.43M Buy
1,840
+4
+0.2% +$2.98K 0.07% 93
2025
Q2 		$1.43M Buy
1,836
+51
+3% +$39.6K 0.08% 84
2025
Q1 		$1.47M Buy
1,785
+20
+1% +$16.6K 0.09% 85
2024
Q4 		$1.36M Buy
1,765
+99
+6% +$82K 0.08% 86
2024
Q3 		$1.48M Buy
1,666
+47
+3% +$42.3K 0.09% 81
2024
Q2 		$1.47M Buy
1,619
+906
+127% +$725K 0.09% 79
2024
Q1 		$555K Sell
713
-4
-0.6% -$2.85K 0.04% 142
2023
Q4 		$418K Hold
717
– – 0.03% 153
2023
Q3 		$385K Buy
717
+146
+26% +$75.2K 0.03% 156
2023
Q2 		$268K Sell
571
-31
-5% -$13K 0.02% 182
2023
Q1 		$207K Sell
602
-4
-0.7% -$1.35K 0.02% 195
2022
Q4 		$222K Buy
606
+67
+12% +$23.8K 0.02% 185
2022
Q3 		$174K Sell
539
-3
-0.6% -$951 0.02% 189
2022
Q2 		$176K Buy
542
+15
+3% +$4.5K 0.02% 188
2022
Q1 		$151K Buy
+527
New +$136K 0.01% 208
2018
Q3 		– Sell
-1,642
Closed -$140K – 150
2018
Q2 		$140K Hold
1,642
– – 0.02% 128
2018
Q1 		$127K Hold
1,642
– – 0.02% 132
2017
Q4 		$139K Hold
1,642
– – 0.02% 136
2017
Q3 		$140K Sell
1,642
-455
-22% -$37.3K 0.02% 130
2017
Q2 		$173K Hold
2,097
– – 0.03% 126
2017
Q1 		$176K Hold
2,097
– – 0.03% 121
2016
Q4 		$154K Sell
2,097
-140
-6% -$10.4K 0.03% 125
2016
Q3 		$180K Sell
2,237
-295
-12% -$23.6K 0.03% 120
2016
Q2 		$199K Sell
2,532
-350
-12% -$26.4K 0.04% 118
2016
Q1 		$208K Sell
2,882
-58
-2% -$4.39K 0.04% 116
2015
Q4 		$248K Sell
2,940
-495
-14% -$41.1K 0.05% 110
2015
Q3 		$287K Sell
3,435
-2,551
-43% -$215K 0.06% 102
2015
Q2 		$500K Sell
5,986
-825
-12% -$62.9K 0.1% 78
2015
Q1 		$495K Buy
6,811
+538
+9% +$38.3K 0.09% 85
2014
Q4 		$433K Buy
6,273
+25
+0.4% +$1.69K 0.08% 84
2014
Q3 		$405K Buy
6,248
+640
+11% +$40.5K 0.08% 88
2014
Q2 		$349K Buy
5,608
+725
+15% +$43.3K 0.07% 93
2014
Q1 		$287K Buy
4,883
+360
+8% +$20.1K 0.06% 97
2013
Q4 		$231K Sell
4,523
-2,625
-37% -$131K 0.05% 103
2013
Q3 		$360K Sell
7,148
-1,000
-12% -$52.4K 0.08% 91
2013
Q2 		$400K Buy
+8,148
New +$443K 0.09% 78

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Acropolis Investment Management's LLY Position: Q2 2026 in Review

Acropolis Investment Management increased its Eli Lilly (LLY) stake by 3.1% in Q2 2026, buying an estimated $62.3K and bringing the position to 2,014 shares worth $2.42M. The position accounts for 0.1% of the portfolio, ranked #74.

Acropolis Investment Management first reported a position in LLY in Q2 2013 and has held it in 39 quarters since. 1,941 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Acropolis Investment Management held 2,014 shares of Eli Lilly worth $2.42M as of Q2 2026.
  • Acropolis Investment Management bought 61 Eli Lilly shares in Q2 2026, an estimated $62.3K.
  • Eli Lilly made up 0.1% of Acropolis Investment Management's portfolio in Q2 2026, its #74 holding.
  • Acropolis Investment Management first reported a position in Eli Lilly in Q2 2013 and has held it in 39 quarters since.
  • 1,941 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Acropolis Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.